![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Zhejiang Hengkang Deferasirox](https://www.pharmacompass.com/image/flap/zhejiang-hengkang-deferasirox-desktop-headergif-47537.gif)
![Zhejiang Hengkang Deferasirox](https://www.pharmacompass.com/image/flap/zhejiang-hengkang-deferasirox-mob-headergif-65088.gif)
01 Aozeal Certified Standards (2)
02 Alkaloids Corporation (4)
03 Creative Peptides (1)
04 PC100047 (4)
05 Piramal Pharma Solutions (3)
06 USP (2)
01 1218-69-5 (2)
02 1688656-83-8 (1)
03 1972-71-0 (2)
04 201530-41-8 (4)
05 201530-79-2 (2)
06 2254105-61-6 (2)
07 NA (2)
08 Blank (1)
01 Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer...) is an iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose. More information please visit the website: http://www.creative-peptides.com/product/deferasirox-item-10-101-115-36.html (1)
02 In stock (2)
03 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No (1)
04 USMCA- No; KORUS- No (1)
05 Blank (11)
01 India (4)
02 U.S.A (8)
03 Blank (4)